Effects of dexamphetamine with and without alcohol on simulated driving

Psychopharmacology (Berl). 2012 Aug;222(3):391-9. doi: 10.1007/s00213-011-2549-0. Epub 2011 Nov 11.

Abstract

Rationale: In party circuits dexamphetamine is frequently used in combination with alcohol. It is hypothesized that co-administration of dexamphetamine to alcohol might reduce the sedative effects of alcohol, but may potentiate risk-taking behaviour.

Objectives: The study was aimed at assessing the effects of alcohol, dexamphetamine and the combination of both on simulated driving and cognitive performance.

Method: Eighteen subjects participated in a randomized, crossover, placebo-controlled study employing four conditions: 10 mg dexamphetamine, 0.8 g/kg alcohol, 10 mg dexamphetamine + 0.8 g/kg alcohol, and placebo. Fundamental driving skills and risk-taking behaviour were assessed in a driving simulator. Subjects also completed vigilance and divided attention tasks, and subjective ratings.

Results: Mean BAC levels during simulated driving were between 0.91‰ and 0.64‰. Subjects using alcohol showed a significantly larger mean standard deviation of lateral position and shorter accepted gap time and distance. Use of alcohol or dexamphetamine + alcohol was associated with a higher frequency of red light running and collisions than the dexamphetamine or placebo conditions. Performance of vigilance and divided attention tasks was significantly impaired in the alcohol condition and, to a lesser degree, in the dexamphetamine + alcohol condition.

Conclusion: Single doses of 0.8 g/kg alcohol increased risk-taking behaviours and impaired tracking, attention and reaction time during a 3-h period after drinking when BACs declined from 0.9 to 0.2 mg/ml. The stimulatory effects of co-administration of dexamphetamine 10 mg were not sufficient to overcome the impairing effects of alcohol on skills related to driving.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Automobile Driving*
  • Central Nervous System Stimulants / pharmacology*
  • Cross-Over Studies
  • Dextroamphetamine / pharmacology*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Ethanol / pharmacology*
  • Humans
  • Male
  • Psychomotor Performance / drug effects*
  • Sleep / drug effects
  • Surveys and Questionnaires

Substances

  • Central Nervous System Stimulants
  • Ethanol
  • Dextroamphetamine